LifeVantage

LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. The firm operates through the following geographical segments: Americas Region, and Asia/Pacific and Europe Region. Its products include Protandim, LifeVantage Omega+ and ProBio, TrueScience and Petandim for dogs. The company was founded in June 1988 and is headquartered in Sandy, UT.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

LifeVantage reports 7.5% revenue growth, eyes expansion into new markets

LifeVantage's Q1 2023 results reflect strong revenue growth driven by the Americas region and successful product launches. The company's LV360 initiative and new compensation plan have shown promising results. However, challenges in the Asia Pacific and Europe region need to be addressed. The fiscal 2023 outlook presents opportunities for continued growth and expansion into new markets.

LifeVantage reports revenue growth in Q2, driven by LV360 strategy

LifeVantage's Q2 saw revenue growth, improved engagement, and successful resolution of supply chain challenges. The introduction of LV360 and product innovations drove performance. Challenges in supply chain management persist, but opportunities for growth are present.

LifeVantage reports revenue growth and product innovation in Q3

LifeVantage's Q3 performance reflects revenue growth, strong financials, and product innovation, with a focus on market expansion.
While challenges exist in regional revenue declines and market uncertainties, the company's strengths in the Americas region and product launches offer growth opportunities.
Maintaining financial stability, enhancing consultant growth, and leveraging new products position LifeVantage for continued success and market leadership.
Overall, LifeVantage's strategic initiatives and financial performance indicate a resilient business model with growth potential and shareholder value.

LifeVantage reports strong Q4 earnings, unveils special dividend for shareholders

LifeVantage's Q4 2023 results reflect robust revenue growth and improved profitability, driven by strategic initiatives and product performance. The company's commitment to shareholder value through dividends and its transformation plan underscores a positive outlook for future growth. While challenges exist, opportunities in product innovation and market expansion position LifeVantage well for continued success.

LifeVantage posts robust Q1 results, eyes international growth opportunities

LifeVantage delivered a strong Q1 2024 performance with revenue growth and improved profitability, driven by successful product sales and international expansion.
Despite challenges like currency fluctuations, the company's financial stability, strategic capital allocation, and growth outlook position it well for future success.
Opportunities in product innovation, international markets, and strategic investments underscore potential avenues for continued growth and value creation for shareholders.
Investors can be optimistic about LifeVantage's trajectory, supported by its solid financial foundation and clear strategic focus on maximizing shareholder value.

LifeVantage reports strong Q2 earnings, eyes growth through product innovation

LifeVantage showcased robust financial performance with notable EBITDA growth and revenue per consultant increase, despite a slight revenue decline.
The company's focus on product innovation, market expansion, and shareholder value enhancement positions it well for future growth and competitiveness.
Strategies to address revenue challenges, capitalize on growth opportunities, and navigate market dynamics will be crucial for sustained success.

LifeVantage reports robust Q3 performance amidst revenue challenges and growth opportunities

LifeVantage demonstrated strong operational performance and profitability improvements in Q3, despite revenue challenges.
The company's focus on consultant enrollment, new product launches, and financial stability are key strengths.
While facing revenue and margin pressures, LifeVantage has opportunities to drive growth through market expansion and product optimization.
Strategic initiatives to address challenges and capitalize on opportunities will be crucial for sustained success in future quarters.

LifeVantage reports Q4 results, eyes growth with loyalty programs

LifeVantage's Q4 2024 performance showed revenue decline but improved margins and strategic initiatives.
Strengths lie in loyalty program enhancements, positive financials, and a promising outlook for fiscal 2025.
Challenges include leadership changes, revenue decline, and the need for sustained growth in active accounts.
Opportunities exist in product launches, retention strategies, and market expansion for the company's growth.
headline

LifeVantage reports robust Q1 earnings, eyes international expansion for growth

LifeVantage's Q1 2025 showcased strong profitability despite revenue decline, driven by the successful MindBody GLP-1 System launch.
Guidance for fiscal 2025 indicates a positive outlook with revenue and EBITDA projections, supported by plans for international product expansion.
While facing revenue challenges, the company's focus on innovation, market demand, and strategic growth initiatives present opportunities for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. Its products include Protandim, Axio, TrueScience, PhysIQ, and Petandim. It operates through the Americas, and Asia or Pacific and Europe geographical segments. The company was founded in June 1988 and is headquartered in Lehi, UT.

Duckhorn Portfolio

As of Dec. 20, 2024, three stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Top 3 Risk Off Stocks That May Collapse This Month

LifeVantage Corporation (NASDAQ:LFVN ) Q1 2025 Earnings Conference Call October 29, 2024 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - President & Chief Executive Officer Carl Aure - Chief Financial Officer Conference Call Participants Douglas Lane - Water Tower Research Operator Good day, ladies and gentlemen. Thank you for standing by.

LifeVantage Corporation (LFVN) Q1 2025 Earnings Call Transcript

SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its first fiscal quarter ended September 30, 2024.

LifeVantage Announces Financial Results for the First Quarter of Fiscal 2025

SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid December 16, 2024 to all stockholders of record at the close of business on December 2, 2024.

LifeVantage Declares Quarterly Dividend

SALT LAKE CITY, Oct. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its first quarter ended September 30, 2024, after the stock market closes on Tuesday, October 29, 2024. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

LifeVantage to Announce First Quarter Fiscal Year 2025 Results on October 29, 2024

Met With High Demand, the Dual-Product System is Clinically Shown to Increase GLP-1 by 140% on average to Balance Hunger Hormones and Reduce Cravings, Supporting Sustainable Weight and Visceral Fat Loss While Maintaining Muscle ‡Ω

LifeVantage Introduces the MindBody GLP-1 System™ Transforming Weight Management into a Sustainable Lifestyle

Enhancements simplify the path to success for independent Consultants Enhancements simplify the path to success for independent Consultants

LifeVantage Announces Update to Evolve Compensation Plan with New Sharing Bonus

SALT LAKE CITY, Sept. 04, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the H.C. Wainwright 26th Annual Global Investment Conference, to be held September 9-11, 2024 in New York, NY.

LifeVantage to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

LifeVantage Corporation (NASDAQ:LFVN ) Q4 2024 Earnings Conference Call August 28, 2024 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - President & CEO Carl Aure - CFO Conference Call Participants Douglas Lane - Water Tower Research Operator Good day, ladies and gentlemen. Thank you for standing by.

LifeVantage Corporation (LFVN) Q4 2024 Earnings Call Transcript

SALT LAKE CITY, Aug. 28, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth quarter and full fiscal year ended June 30, 2024.

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2024

SALT LAKE CITY, Aug. 26, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, announced the appointment of Rajendran Anbalagan to the Company's Board of Directors effective today. The appointment comes after the Board conducted a comprehensive search to identify a candidate with transformational digital skills and identified Mr. Anbalagan as an exceptional choice.

LifeVantage Welcomes Rajendran Anbalagan to the Board of Directors; Thanks Erin Brockovich for Her Years of Service

Event highlighted new weight management products while fostering strategic collaboration and recognition among Consultants Event highlighted new weight management products while fostering strategic collaboration and recognition among Consultants

LifeVantage Concludes Rise Retreat in Park City with Exclusive Preview of New Innovative Weight Management Solution

SALT LAKE CITY, Aug. 14, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2024, after the stock market closes on Wednesday, August 28, 2024. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2024 Results on August 28, 2024

Enhancements leverage increased Customer retention to drive value and engagement Enhancements leverage increased Customer retention to drive value and engagement

LifeVantage Optimizes Rewards Circle with New Benefits for Both Consultants and Customers

Calls will highlight how company is ahead of industry with recent transformation initiatives, innovative compensation plan, award-winning, activating products, and vibrant entrepreneurial community Calls will highlight how company is ahead of industry with recent transformation initiatives, innovative compensation plan, award-winning, activating products, and vibrant entrepreneurial community

LifeVantage To Host “LifeVantage Open House” Virtual Calls on July 23 and 24

Reaffirms commitment to direct selling industry and its vibrant community Reaffirms commitment to direct selling industry and its vibrant community

LifeVantage Hosts Global Activate 2024 Event Teasing Major Product Launch

SALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer, and Carl Aure, Chief Financial Officer, will be participating in the following investor conferences during the month of June:

LifeVantage To Participate in Upcoming Investor Conferences

LifeVantage Corporation (NASDAQ:LFVN ) Q3 2024 Earnings Conference Call May 2, 2024 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - President & Chief Executive Officer Carl Aure - Chief Financial Officer Conference Call Participants Doug Lane - Water Tower Research Operator Good day, ladies and gentlemen. Thank you for standing by.

LifeVantage Corporation (LFVN) Q3 2024 Earnings Call Transcript

SALT LAKE CITY, April 18, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its third quarter ended March 31, 2024, after the stock market closes on Thursday, May 2, 2024. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

LifeVantage to Announce Third Quarter Fiscal Year 2024 Results on May 2, 2024

US Consultants converge in Nashville for a dynamic summit propelling the Company's 'Rise Era' forward US Consultants converge in Nashville for a dynamic summit propelling the Company's 'Rise Era' forward

LifeVantage Wraps Up Momentum Academy 2024 with a Focus on Entrepreneurship and Growth

Revolutionary, Results-Driven Formulas for the Busy, Ingredient-Conscious Skincare Consumer Revolutionary, Results-Driven Formulas for the Busy, Ingredient-Conscious Skincare Consumer

LifeVantage Transforms the Future of Skin Health and Radiance: Introducing the TrueScience® Activated Skin Care Collection

SALT LAKE CITY, Feb. 16, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the Winter Wrap Up MicroCap Rodeo Virtual Conference, to be held February 20-23, 2024.

LifeVantage to Participate in the Winter Wrap Up MicroCap Rodeo Conference

SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Dayton Judd to the Company's Board of Directors (the “Board”), effective immediately, in an expansion of the Board. The Company has had discussions with Bradley L.

LifeVantage Appoints Dayton Judd to the Board of Directors

LifeVantage Corporation (LFVN) Q2 2024 Earnings Call Transcript

SALT LAKE CITY, Jan. 30, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its second fiscal quarter ended December 31, 2023.

News for LifeVantage Stock (LFVN)